Palomino Laboratories Inc.
PALX· OTC
PALXPalomino Laboratories Inc.
Filed Mar 28, 2025 · 10-K · 87 days after period end · 0001013762-25-004263
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures |
|---|---|---|
| Net Income | -$9.96K | -$32.57K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palomino Laboratories Inc. · CIK 1938569 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 28, 2025 · 87 d after period end
